Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Gene Therapy

Home » Gene Therapy
Gene Therapy Milestone: Elevated FIX Levels Achieved in Chinese Hemophilia B Patients

Gene Therapy Milestone: Elevated FIX Levels Achieved in Chinese Hemophilia B Patients

Posted by By Ran Zhang 2024.03.06
In January 2023, Professor Jianmin Wang from Department of Hematology, Shanghai Changhai Hospital published a commentary on Blood Science. The title of the study is "Big stride in gene therapy for hemophilia B…
Read More
2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients

2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients

Posted by By Yin, Jiale 2024.01.26
From January 5th to 7th, 2024, the 4th China/Academy of Hematology Sciences Development Conference (CASH) was grandly held in Tianjin. Continuing with the theme "Comprehensive Hematology, Healthcare, and Wellness", this…
Read More
2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors

2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors

Posted by By Yin, Jiale 2024.01.26
β-thalassemia is a hereditary blood disorder caused by mutations in the β-globin gene, leading to impaired synthesis or structural changes in β-globin. Gene therapy for β-thalassemia using lentiviral vectors refers…
Read More
Recent Posts
  • ASCO China Voice | Zhenzhen Liu: HELEN Series Studies Presented at ASCO Advance Precision Treatment Strategies for Breast Cancer
  • ASCO China Voice | Xiaowei Qi: Pembrolizumab-Free Anthracycline-Sparing Neoadjuvant Regimen with Penpulimab, Taxane, and Carboplatin Demonstrates Promising Efficacy and Safety in Triple-Negative Breast Cancer
  • ASCO China Voice | Zhimin Shao and Zhonghua Wang’s Team: IRIS-A Study Demonstrates That Capecitabine Plus Trastuzumab Provides Effective, Low-Toxicity De-escalated Adjuvant Therapy for Stage IA HER2-Positive Breast Cancer
  • ASCO China Voice | Jiong Wu: PANKU-Breast02 Meets Both PFS and OS Primary Endpoints, with Iza-Bren Delivering a New Breakthrough for Previously Treated Advanced Triple-Negative Breast Cancer
  • ASCO China Voice | Professor Hui Xie: BMI May Serve as a Simple Stratification Marker for Trastuzumab Deruxtecan in Advanced Breast Cancer
Recent Comments
    Archives
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top